Detalhe da pesquisa
1.
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
Blood
; 139(23): 3366-3375, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081255
2.
A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Haematologica
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572562
3.
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
Am J Hematol
; 99(4): 606-614, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342997
4.
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.
Cancer
; 129(6): 934-945, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36545710
5.
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia.
Curr Treat Options Oncol
; 24(8): 1036-1051, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300657
6.
Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia.
Haematologica
; 107(11): 2641-2649, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511672
7.
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
Cancer
; 127(7): 1039-1048, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259056
8.
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
Haematologica
; 105(12): 2738-2745, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054106
9.
Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
J Natl Compr Canc Netw
; 18(2): 169-175, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32023530
10.
Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.
Oncologist
; 24(9): 1253-1258, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944185
11.
Eligibility criteria: too big, too small or just right?
Haematologica
; 109(4): 1021, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822257
12.
Implementation and evaluation of high-dose methotrexate administration guidelines.
J Oncol Pharm Pract
; 25(7): 1675-1681, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30360674
13.
Dasatinib dose management for the treatment of chronic myeloid leukemia.
Cancer
; 124(8): 1660-1672, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370463
14.
Low-intensity induction in acute myeloid leukemia. Always in the patients' best interest?
Haematologica
; 108(4): 949-950, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35861019
15.
Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia.
BMC Cancer
; 18(1): 359, 2018 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29609532
16.
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 23(8): 1295-1302, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28412518
17.
Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.
Am J Hematol
; 97(7): E232-E235, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338673
18.
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 17(4): 496-508, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26968357
20.
Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS).
Blood
; 122(11): 1974-82, 2013 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847196